SUMMIT
2025

OCTOBER 8-10, 2025 | NASHVILLE, TN

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE NEEDED TO ENABLE PRECISION MEDICINE AT SCALE

Formerly the Genetic Health Information Network Summit

A ONE-OF-A-KIND, COLLABORATIVE FORUM OF INFLUENTIAL LEADERS

The only multi-stakeholder gathering focused on the data, digital infrastructure, and economic challenges facing precision medicine. A forum that includes:

  • Full spectrum of stakeholders: healthcare, policy, technology, science & patients

  • Collaborative, discussion-oriented format

  • Chatham-house rules — non-attribution

  • No sponsored talks, sales pitches or marketing lists

  • Published conference summary and recommendations

A Gathering of Committed Leaders From Across the Entire Healthcare Ecosystem

Health Plans | Clinicians | Hospital Systems | Researchers | Policy Makers | Laboratories | Patients & Advocates | IT Vendors | Pharma

2025 ORGANIZING COMMITTEE

  • JIM ALMAS, MD

    VP & National Medical Director, Clinical Effectiveness
    LabCorp

  • JOANNE ARMSTRONG, MD, MPH

    Chief Medical Officer & VP, Women’s Health & Genomics
    CVS Health

  • MARA ASPINALL

    Partner
    Illumina Ventures

  • CARLOS BUSTAMANTE, PHD

    Founder & CEO
    Galatea Bio, Inc.

  • PETER DEVAULT

    VP, Interoperability & Genomics
    Epic

  • ERIC DISHMAN

    CEO
    DishStrong Innovation, LLC

  • JOHN FOX, MD, MHA

    Senior Medical Director for the Americas, Market Access
    Illumina

  • DAVID HARMON, MD

    Deputy Chief Health Officer
    Centene

  • GILLIAN HOOKER, PHD, SCM, CGC

    Chief Scientific Officer
    Concert

  • STEVE KEILES, MS, CGC

    Executive Director, Genomic Services, Clinical Solutions
    Quest Diagnostics

  • LUCY LANGER, MD, MSHS

    National Medical Director, Oncology & Genomics
    UnitedHealthcare

  • HOWARD LEVY, MD, PHD

    Chief Medical Information Officer
    Maryland Primary Care Physicians

  • LORI PRESTESATER

    SVP, Health Solutions
    American Medical Association (AMA)

  • NICK SEDDON

View the 2025 Agenda

2025 SPEAKERS

  • FRANK HARVEY

    CEO
    Surescripts

  • KATHERINE STUELAND

    CEO
    GeneDx

  • TOM GRAF, MD

    CMO, Medicare
    Florida Blue

  • LEAH TIMMERMAN

    SVP, Health Plans
    Quest Diagnostics

  • MICHAEL SHERMAN, MD

    Principal
    Sherman Healthcare Solutions, LLC

  • SAMYUKTA MULLANGI, MD

    Senior Medical Director
    Thyme Care

  • EZRA COHEN, MD

    CMO, Oncology
    Tempus

  • ASHLEY HUME

    President
    Emerging Therapy Solutions

  • RUSS PAULSEN

    COO
    USAgainstAlzheimer's

  • JIM ALMAS, MD

    VP & National Medical Director, Clinical Effectiveness
    LabCorp

  • MARA ASPINALL

    Partner
    Illumina Ventures

  • CLIFF GOODMAN, PHD

    Moderator
    Independent

PAST SPEAKERS

  • FRANCIS COLLINS, MD, PhD

    Acting Science Advisor to the President of the United States

  • CARLOS BUSTAMONTE, PhD

    Founder & CEO
    Galatea Bio, Inc

  • TRENT HAYWOOD, MD, JD

    SVP & Chief Medical Officer
    Blue Cross Blue Shield Association

  • DEE ANNA SMITH

    CEO
    Sarah Cannon

VIEW ALL

Identify and resolve practical barriers facing precision medicine by

  • Improving the capture of clinical effectiveness and economic value data

  • Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs

  • Streamlining the genetic test billing, adjudication and payment process

  • Reducing the frequency of misordered tests and surprise bills for patients

  • Empowering patients to harness the insights in their genetic makeup for greater health

BACK BY POPULAR DEMAND

The 2024 Summit is back, Driven by Last Year’s Enthusiastic Response and a +88 Net Promoter Score.

Accommodations will be at the Kimpton Aertson, a boutique hotel in Nashville.

1-45759737.jpg
8-58d5d279.jpg
lobby_01-1ca84636.jpg
20-90a1ef69.jpg
joliet-aertson-final-6803-62a5d348.jpg
15-38ad71d2.jpg
joliet-aertson-final-6564_king-corner-balcony-5da74045.jpg
woodlea-terrace-01-99ab6996.jpg
11-5fac915c.jpg

  • “Intimate engagement with key stakeholders in the genomic medicine space that does not otherwise happen all that often…Excellent and efficient organization and moderation with summary of key points throughout.”

    Director, Molecular Pathology

  • “Excellent speakers, panels, participants, and facilitation on relevant topics”

    CEO, genomics company

  • “It was a unique and diverse group of stakeholders with (most importantly) time to interact with each other. Key gaps that need to be bridged were openly discussed and at least understood, if not resolved.”

    Chief Medical Officer

  • “I thought that the summit raised important issues and brought together interested and diverse individuals to exchange ideas and propose serious solutions to real problems in the field.”

    President, advocacy organization

  • “Open discussion, and a focus on actionable takeaways. Attendance by people who are influential.”

    Director, Science Policy

Nominate someone.

This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form: